888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
OV8010bMid-advanced stage ovary cancer tissue array with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV8010
Cores80Cases80
Row number8Column number10
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:OV8010b
 
Mid-advanced stage ovary cancer tissue array with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV8010
 
Price: $255.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Lym
-Lymph node
Ova
-Ovary
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIc)
 
Malignant (III)
 
Malignant (IIIc)
 
Malignant (IV)
 
Metastasis (*)
TISSUE  ARRAYS OV8010b
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
LYM
LYM
LYM
LYM
LYM
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1160FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignant
A2246FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignant
A3326FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
A4465FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A5569FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A6662FOvarySerous papillary adenocarcinoma2T2cN0M0IIcMalignant
A7769FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignant
A8835FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A9949FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignant
A101045FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B11156FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
B21252FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B31350FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B41451FOvarySerous adenocarcinoma3T2cN0M0IIcMalignant
B51538FOvarySerous adenocarcinoma3T2N0M0IIMalignant
B61647FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignant
B71741FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
B81857FOvarySerous adenocarcinoma3T2N0M0IIMalignant
B91956FOvarySerous adenocarcinoma2T2N0M0IIMalignant
B102046FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
C12142FOvarySerous adenocarcinoma2T2bN0M0IIBMalignant
C22239FOvarySerous adenocarcinoma2T2N0M0IIMalignant
C32348FOvarySerous adenocarcinoma3T2bN0M0IIBMalignant
C42453FOvarySerous adenocarcinoma3T2aN0MOIIAMalignant
C52556FOvaryTumor necrosis*T2N0M0IIMalignant
C62637FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
C72773FOvarySerous adenocarcinoma3T2N0M0IIMalignant
C82856FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
C92951FOvarySerous adenocarcinoma3T2N0M0IIMalignant
C103066FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
D13158FOvaryEndometrioid adenocarcinoma (Fibrous tissue)*T2cN0M0IIcMalignant
D23248FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
D33356FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
D43460FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
D53555FOvarySerous adenocarcinoma3T3N1M0IIIcMalignant
D63654FOvarySerous adenocarcinoma (sparse)3T3cN1M0IIIcMalignant
D73743FOvarySerous adenocarcinoma3T3N1M0IIIcMalignant
D83848FOvarySerous adenocarcinoma (sparse)3T3cN1M0IIIcMalignant
D93949FOvarySerous adenocarcinoma3T3N1M0IIIcMalignant
D104065FOvarySerous adenocarcinoma3T3N0M1IVMalignant
E14157FOvarySerous papillary adenocarcinoma (fibrous and blood vessal tissue)*T3cN0M0IIIcMalignant
E24232FOvarySerous papillary adenocarcinoma3T1bN1M0IIIcMalignant
E34342FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
E44456FOvarySerous papillary adenocarcinoma3T3bN1M0IIIcMalignant
E54546FOvarySerous papillary adenocarcinoma3T3N0M0IIIMalignant
E64647FOvarySerous papillary adenocarcinoma3T3N1M0IIIcMalignant
E74741FOvarySerous papillary adenocarcinoma3T3cN0M0IIIcMalignant
E84856FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
E94975FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
E105043FOvarySerous papillary adenocarcinoma3T2cN1M0IIIcMalignant
F15151FOvarySerous papillary adenocarcinoma3T3N1M0IIIcMalignant
F25245FOvarySerous papillary adenocarcinoma3T2N1M0IIIcMalignant
F35359FOvarySerous papillary adenocarcinoma3TeN1M0IIIcMalignant
F45448FOvarySerous papillary adenocarcinoma3T3cN0M0IIIcMalignant
F55566FOvarySerous papillary adenocarcinoma3T3aN1M0IIIcMalignant
F65653FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
F75749FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
F85865FOvarySerous papillary adenocarcinoma3T3cN1M0IIIcMalignant
F95948FOvarySerous papillary adenocarcinoma3T3cN0M0IIIcMalignant
F106065FOvarySerous papillary adenocarcinoma3T2N1M0IIIcMalignant
G16143FOvaryMucinous papillary adenocarcinoma1T3cN0M0IIIcMalignant
G26251FOvaryMucinous adenocarcinoma3T3N0M1IVMalignant
G36348FOvaryMucinous adenocarcinoma3T2N0M1IVMalignant
G46441FOvaryMucinous adenocarcinoma3T3N1M1IVMalignant
G56550FOvaryMucinous papillary adenocarcinoma3T2aN0M1IVMalignant
G66662FOvaryMucinous papillary adenocarcinoma3T2aN0M1IVMalignant
G76741FOvaryMucinous papillary adenocarcinoma3T3cN1M1IVMalignant
G86829FOvaryAdenocarcinoma3T3cN0M1IVMalignant
G96947FOvaryClear cell carcinoma*T3cN1M1IVMalignant
G107060FOvaryEndometrioid adenocarcinoma with necrosis*T3N1M1IVMalignant
H17150FOvaryEndometrioid adenocarcinoma1T2N0M1IVMalignant
H27259FOvaryEndometrioid adenocarcinoma3T2N0M1IVMalignant
H37368FOvaryEndometrioid adenocarcinoma3T2aN0M1IVMalignant
H47455FOvaryTransitional cell carcinoma3T1N0M1IVMalignant
H57552FOvaryTransitional cell carcinoma3T2N0M1IVMalignant
H67659FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
H77774FLymph nodeMetastatic serous adenocarcinoma from omenta3**Metastasis
H87855FLymph nodeMetastatic serous adenocarcinoma from omenta2**Metastasis
H97947FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
H108054FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
Tissue Marker
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs